BioSig (BSGM) Continues to Advance with FDA 510(K) Clearance and NASDAQ Uplisting on the Horizon
29 Aug
2018
Written by Mike Elliott

BioSig (BSGM) Continues to Advance with FDA 510(K) Clearance and NASDAQ Uplisting on the Horizon »

In the interview, Ken discusses the recent 510(k) clearance for its first product, PURE EP System, from the U.S. Food and Drug Administration (FDA).

Read more...
BioSig (BSGM) Looking Undervalued with Disruptive Technology in $4B EP Market
18 Jul
2018
Written by Mike Elliott

BioSig (BSGM) Looking Undervalued with Disruptive Technology in $4B EP Market »

In this episode of the CEOLIVE Investor Profile series, we’re joined by Ken Londoner, Chairman, and CEO of BioSig Technologies, ticker BSGM.

Read more...
Precision Therapeutics (AIPT) Bringing Big Data and AI to Precision Medicine
26 Mar
2018
Written by Mike Elliott

Precision Therapeutics (AIPT) Bringing Big Data and AI to Precision Medicine »

Precision Therapeutics (AIPT) operates in two business areas: first, applying artificial intelligence to personalized medicine and drug discovery to provide personalized medicine solutions for clients in the pharmaceutical, diagnostic, and biotech industries, and second, production of the FDA-approved STREAMWAY® System for automated, direct-to-drain medical fluid disposal.

Read more...
$MLSS | Medical R&D Co. With Innovative Portfolio
13 Aug
2015
Written by Mike Elliott

$MLSS | Medical R&D Co. With Innovative Portfolio »

Milestone Scientific is a leading medical research and development company that designs and patents innovative injection technology.

Read more...
$MBVX CEOLIVE Insider Report | MabVax Therapeutics Holdings
8 Jul
2015
Written by Mike Elliott

$MBVX CEOLIVE Insider Report | MabVax Therapeutics Holdings »

MabVax Therapeutics Holdings, Inc. is cancer diagnostic and immunotherapy company focused on the development of vaccine and antibody based therapies to address unmet medical needs in the treatment of cancer.

Read more...

Login

Lost your password?